COMP <GO>
ELV vs UNH // RETURN ON INVESTED CAPITAL (ROIC)
Elevance Health Inc. (NYSE) VS. UnitedHealth Group Incorporated (NYSE) • 15-METRIC TALLY: ELV 6
— UNH 8
▲ RETURN ON INVESTED CAPITAL (ROIC) LEADER: UNH
LAST: $420.07 (-0.46%) • MKT CAP: $91.18B
roic
8.70%
LAST: $406.97 (-0.96%) • MKT CAP: $364.66B
roic
11.47%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (ELV VS. UNH)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | ELV | UNH | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 89.40% | 88.57% | +0.83 | ELV | /gross-margins <GO> |
| Return on Invested Capital (ROIC) ACTIVE | 8.70% | 11.47% | -2.77 | UNH | /roic <GO> |
| EV/EBITDA & P/E Valuation | 13.8x | 16.4x | -2.65 | ELV | /valuation <GO> |
| Free Cash Flow Yield | 3.48% | 6.48% | -3.00 | UNH | /fcf-yield <GO> |
| Operating Margin | 3.60% | 4.82% | -1.22 | UNH | /operating-margins <GO> |
| Net Profit Margin | 2.80% | 3.14% | -0.34 | UNH | /net-margins <GO> |
| Revenue Growth (YoY) | 12.50% | 6.46% | +6.04 | ELV | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 1.68% | 2.28% | -0.60 | UNH | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 3.17 | 3.12 | +0.05 | ELV | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 7/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 7.10% | 6.74% | +0.36 | UNH | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 50.8 | 56.0 | -5.28 | UNH | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.07 | 0.33 | +0.74 | ELV | /macro-sensitivity <GO> |
| Forward P/E Multiple | 13.5x | 17.1x | -3.59 | ELV | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $91.18B | $364.66B | -$273.48B | UNH | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | ELV REV | UNH REV | ELV GROSS % | UNH GROSS % | ELV FCF | UNH FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $199.13B | $447.57B | 89.4% | 88.7% | $3.17B | $16.07B |
| FY 2024 | $177.01B | $400.28B | 88.8% | 88.3% | $4.55B | $20.70B |
| FY 2023 | $171.34B | $371.62B | 44.0% | 89.6% | $350.7M | $25.68B |
| FY 2022 | — | $324.16B | — | 89.6% | — | $23.40B |
| FY 2021 | — | $287.60B | — | 89.2% | — | $19.89B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
ELV // BETA 1.07
UNH // BETA 0.33